This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
News
The stories you loved in 2023
From a major collaboration looking for the earliest signs of age-related macular degeneration, to our plans for the future of eye clinical trials in Australia, here are the CERA stories you read the most in 2023.